Medicare Enrolled
Dr. Mariuxi Viteri Malone, M.D.
Hematology · Venice, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Viteri Malone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Viteri Malone? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Viteri Malone
Dr. Mariuxi Viteri Malone is a hematology in Venice, FL, with 10 years in practice. Based on federal Medicare data, Dr. Viteri Malone performed 205,356 Medicare services across 6,177 unique beneficiaries.
Between the years covered by Open Payments, Dr. Viteri Malone received a total of $8,024 from 60 pharmaceutical and/or device companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Viteri Malone is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice▲ Top 19% volume in FL$ $8,024 industry payments
Medicare Practice Summary
Medicare Utilization ↗205,356
Medicare services
Top 19% in FL for hematology
6,177
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,536 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 40,100 | $0 | $5 |
| Iron infusion (Feraheme) | 24,480 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 20,600 | $43 | $137 |
| Contrast dye for imaging (iodine-based) | 18,604 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 15,210 | $1 | $5 |
| Filgrastim injection (Nivestym) for white blood cells | 15,060 | $0 | $1 |
| Filgrastim injection (Zarxio) for white blood cells | 9,660 | $0 | $2 |
| Azacitidine chemotherapy injection | 9,400 | $0 | $4 |
| Oxaliplatin chemotherapy injection | 8,800 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 7,680 | $18 | $51 |
| Paclitaxel chemotherapy injection | 4,415 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 3,470 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 3,092 | $36 | $108 |
| Iron infusion (Monoferric) | 2,800 | $16 | $57 |
| Dexamethasone injection (steroid) | 2,635 | $0 | $3 |
| Injection, eflapegrastim-xnst, 0.1 mg | 2,508 | $26 | $116 |
| Blood draw (venipuncture) | 2,424 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,407 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,300 | $1 | $28 |
| Injection, atropine sulfate, 0.01 mg | 1,040 | $0 | $1 |
| Office visit, established patient (30-39 min) | 898 | $95 | $339 |
| Drug injection, under skin or into muscle | 705 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 612 | $0 | $9 |
| Injection, leucovorin calcium, per 50 mg | 580 | $3 | $12 |
| Office visit, established patient (20-29 min) | 570 | $64 | $239 |
| Injection of additional new drug or substance into vein | 528 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 447 | $97 | $378 |
| Injection, fluorouracil, 500 mg | 398 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 395 | $48 | $189 |
| Injection, irinotecan, 20 mg | 353 | $2 | $177 |
| Injection, magnesium sulfate, per 500 mg | 306 | $1 | $2 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 296 | $22 | $84 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 288 | $1 | $6 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 228 | $17 | $59 |
| Injection, carboplatin, 50 mg | 213 | $2 | $41 |
| Ct scan of chest with contrast | 184 | $54 | $344 |
| Infusion into a vein for hydration, each additional hour | 171 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 171 | $21 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 153 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 143 | $16 | $56 |
| CT scan of abdomen and pelvis with contrast | 138 | $173 | $550 |
| Injection of drug or substance into vein | 138 | $28 | $156 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 137 | $401 | $680 |
| Prothrombin time test (blood clotting) | 124 | $4 | $15 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 116 | $1,099 | $3,706 |
| Infusion, normal saline solution , 1000 cc | 108 | $2 | $7 |
| Injection, zoledronic acid, 1 mg | 105 | $6 | $69 |
| Office visit, established patient, complex (40-54 min) | 92 | $137 | $474 |
| Administration of additional new drug or substance into vein, 1 hour or less | 88 | $49 | $178 |
| Red blood count automated, with additional calculations | 87 | $5 | $20 |
| New patient office visit, complex (60-74 min) | 73 | $165 | $585 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 68 | $53 | $206 |
| Hospital follow-up visit, moderate complexity | 67 | $62 | $197 |
| Administration of additional new drug or substance into vein using push technique | 63 | $42 | $170 |
| Infusion into a vein for hydration, 31-60 minutes | 54 | $24 | $156 |
| Drawing of blood for a medical problem | 54 | $68 | $277 |
| Initial hospital admission, high complexity | 53 | $136 | $556 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 48 | $25 | $89 |
| New patient office visit (45-59 min) | 47 | $124 | $453 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 46 | $124 | $637 |
| Automated urinalysis | 41 | $2 | $8 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 40 | $3 | $11 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 36 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 34 | $15 | $56 |
| Nuclear medicine study whole body with ct scan | 29 | $1,098 | $3,706 |
| Red blood count, automated test | 28 | $4 | $10 |
| CT scan of chest, without contrast | 27 | $39 | $362 |
| Hospital follow-up visit, high complexity | 26 | $94 | $285 |
| Ct scan of soft tissue of neck with contrast | 24 | $65 | $712 |
| Administration of chemotherapy into vein using push technique | 22 | $76 | $303 |
| Ct scan of abdomen and pelvis without contrast | 19 | $84 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.4% high complexity
80.9% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,024
Total received (2018-2024)
Avg $1,605/year across 5 years
Top 48% in FL for hematology
60
Companies
344
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,494 (93.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$530 (6.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,782
2023$3,797
2022$1,221
2019$125
2018$98
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$549
Astellas Pharma US Inc
$515
Merck Sharp & Dohme LLC
$461
Daiichi Sankyo Inc.
$430
Celgene Corporation
$420
Novartis Pharmaceuticals Corporation
$411
Janssen Biotech, Inc.
$374
Incyte Corporation
$329
SOBI, INC
$248
Takeda Pharmaceuticals U.S.A., Inc.
$239
Gilead Sciences, Inc.
$239
Regeneron Healthcare Solutions, Inc.
$233
Immunocore Limited
$225
Seagen Inc.
$223
PFIZER INC.
$219
Genentech USA, Inc.
$184
AstraZeneca Pharmaceuticals LP
$181
Blueprint Medicines Corporation
$161
Lilly USA, LLC
$158
ARRAY BIOPHARMA INC
$156
Amgen Inc.
$149
Exelixis Inc.
$136
GlaxoSmithKline, LLC.
$126
Eisai Inc.
$120
BeiGene USA, Inc.
$104
MorphoSys, US Inc.
$91
Kite Pharma, Inc.
$88
Kyowa Kirin, Inc.
$85
JAZZ PHARMACEUTICALS INC.
$71
Mirati Therapeutics, Inc.
$71
Sumitomo Pharma America, Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
EISAI INC.
$64
GENZYME CORPORATION
$61
Pharmacyclics LLC, An AbbVie Company
$52
TAIHO ONCOLOGY, INC.
$51
ImmunoGen, Inc.
$50
Bayer Healthcare Pharmaceuticals Inc.
$46
ABBVIE INC.
$42
Pharmacosmos Therapeutics Inc.
$42
EMD Serono, Inc.
$39
Aveo Pharmaceuticals, Inc.
$39
AVEO Pharmaceuticals, Inc.
$33
Karyopharm Therapeutics Inc.
$32
Agios Pharmaceuticals, Inc.
$32
Rigel Pharmaceuticals, Inc.
$30
ADC Therapeutics America, Inc.
$27
SERVIER PHARMACEUTICALS LLC
$25
PharmaEssentia USA Corporation
$24
G1 Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$24
Taiho Oncology, Inc.
$22
Epizyme, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Deciphera Pharmaceuticals Inc.
$19
Sobi, Inc
$18
Alexion Pharmaceuticals, Inc.
$17
CTI BioPharma Corp.
$15
Myovant Sciences Inc.
$14
Sirtex Medical Inc
$13
Top 3 companies account for 19.0% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRILINTA · BRUKINSA · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · COSELA · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · ERLEADA · Elahere · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KIMMTRAK · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MONJUVI · MONOFERRIC · NINLARO · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · Stivarga · TASIGNA · TECVAYLI · TIVDAK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · VERZENIO · VONJO · Venclexta · Vonjo · Vyloy · XALKORI · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEPZELCA · ZYNYZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
21
Per 100K population
4.7
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL - VENICE
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Viteri Malone is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Viteri Malone experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Viteri Malone performed 40,100 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Viteri Malone receive payments from pharmaceutical companies?
Yes. Dr. Viteri Malone received a total of $8,024 from 60 companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Viteri Malone's costs compare to other hematologys in Venice?
Dr. Viteri Malone's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Viteri Malone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Venice
Browse hematologys in Venice ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology